A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by the FDA, and the partners have now withdrawn a filing intended to get the ...
Bowl of Quick Cook on MSN
Drive Smarter, Drive Safer: How Today's Cars Are Revolutionizing Your Protection on the Road
Since their invention in the 19th century, cars have transformed from simple transportation to sophisticated safety allies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback